ATYR PHARMA INC

Ticker: ATYR CUSIP: 002120202 Class: Common Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 511,412 Value ($000) $2,593 Avg Close $3.93 Range $2.30 - $5.98
Q1 2025
Shares 838,452 Value ($000) $2,532 Avg Close $3.65 Range $2.71 - $4.66
Q3 2024
Shares 14,031 Value ($000) $25 Avg Close $1.82 Range $1.48 - $2.50
Q1 2024
Shares 158,619 Value ($000) $309 Avg Close $1.74 Range $1.39 - $2.15
Q1 2023
Shares 10,947 Value ($000) $23 Avg Close $2.19 Range $1.81 - $2.62
Q4 2022
Shares 140,296 Value ($000) $307 Avg Close $2.36 Range $2.00 - $3.07
Q3 2022
Shares 175,910 Value ($000) $527 Avg Close $3.35 Range $2.70 - $4.28
Q2 2022
Shares 159,407 Value ($000) $450 Avg Close $3.62 Range $2.60 - $5.97
Q1 2022
Shares 203,007 Value ($000) $1,086 Avg Close $5.67 Range $4.51 - $8.25
Q4 2021
Shares 250,396 Value ($000) $1,871 Avg Close $8.35 Range $7.23 - $9.95
Q3 2021
Shares 43,006 Value ($000) $390 Avg Close $5.98 Range $4.22 - $13.10